Update on immune checkpoint inhibitors in gynecological cancers
10.3802/jgo.2017.28.e20
Saved in:
Main Authors: | Heong, Valerie, Ngoi, Natalie, Tan, David Shao Peng |
---|---|
Other Authors: | MEDICINE |
Format: | Review |
Language: | English |
Published: |
KOREAN SOC GYNECOLOGY ONCOLOGY & COLPOSCOPY
2021
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/206512 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Language: | English |
Similar Items
-
Lynch syndrome among gynecologic oncology patients meeting Bethesda guidelines for screening
by: Walsh, C.S., et al.
Published: (2011) -
A multi‐ethnic analysis of immune‐related gene expression signatures in patients with ovarian clear cell carcinoma
by: Heong, Valerie, et al.
Published: (2021) -
DEVELOPMENT OF LIPOSOME FORMULATIONS CO-ENCAPSULATING TOPOISOMERASE INHIBITORS IRINOTECAN AND DOXORUBICIN FOR THE TREATMENT OF OVARIAN CANCER
by: SHAIKH MOHAMMED ISHAQUE
Published: (2012) -
Understanding the genetic basis of gastric cancer: Recent advances
by: Tan, I.B., et al.
Published: (2014) -
Liposome co-encapsulation of synergistic combination of irinotecan and doxorubicin for the treatment of intraperitoneally grown ovarian tumor xenograft
by: Shaikh, I.M., et al.
Published: (2014)